448 related articles for article (PubMed ID: 18817982)
21. Isolation and molecular characterization of the porcine transforming growth factor beta type I receptor (TGFBR1) gene.
Chen K; Rund LA; Beever JE; Schook LB
Gene; 2006 Dec; 384():62-72. PubMed ID: 16950575
[TBL] [Abstract][Full Text] [Related]
22. Age-dependent effects of TWEAK/Fn14 receptor activation on neural progenitor cells.
Hamill CA; Michaelson JS; Hahm K; Burkly LC; Kessler JA
J Neurosci Res; 2007 Dec; 85(16):3535-44. PubMed ID: 17803219
[TBL] [Abstract][Full Text] [Related]
23. TWEAK/Fn14 pathway: an immunological switch for shaping tissue responses.
Burkly LC; Michaelson JS; Zheng TS
Immunol Rev; 2011 Nov; 244(1):99-114. PubMed ID: 22017434
[TBL] [Abstract][Full Text] [Related]
24. TWEAK-Fn14 pathway inhibition protects the integrity of the neurovascular unit during cerebral ischemia.
Zhang X; Winkles JA; Gongora MC; Polavarapu R; Michaelson JS; Hahm K; Burkly L; Friedman M; Li XJ; Yepes M
J Cereb Blood Flow Metab; 2007 Mar; 27(3):534-44. PubMed ID: 16835630
[TBL] [Abstract][Full Text] [Related]
25. FGF-inducible 14-kDa protein (Fn14) is regulated via the RhoA/ROCK kinase pathway in cardiomyocytes and mediates nuclear factor-kappaB activation by TWEAK.
Chorianopoulos E; Heger T; Lutz M; Frank D; Bea F; Katus HA; Frey N
Basic Res Cardiol; 2010 Mar; 105(2):301-13. PubMed ID: 19629561
[TBL] [Abstract][Full Text] [Related]
26. Proinflammatory effect of TWEAK/Fn14 interaction in human retinal pigment epithelial cells.
Ebihara N; Nakayama M; Tokura T; Iwatsu M; Ushio H; Murakami A
Curr Eye Res; 2009 Oct; 34(10):836-44. PubMed ID: 19895311
[TBL] [Abstract][Full Text] [Related]
27. Role of the TWEAK/Fn14 pathway in autoimmune diseases.
Xu WD; Zhao Y; Liu Y
Immunol Res; 2016 Feb; 64(1):44-50. PubMed ID: 26659091
[TBL] [Abstract][Full Text] [Related]
28. Isolation and molecular characterization of the porcine stearoyl-CoA desaturase gene.
Ren J; Knorr C; Huang L; Brenig B
Gene; 2004 Sep; 340(1):19-30. PubMed ID: 15556291
[TBL] [Abstract][Full Text] [Related]
29. TWEAK is a positive regulator of cardiomyocyte proliferation.
Novoyatleva T; Diehl F; van Amerongen MJ; Patra C; Ferrazzi F; Bellazzi R; Engel FB
Cardiovasc Res; 2010 Mar; 85(4):681-90. PubMed ID: 19887380
[TBL] [Abstract][Full Text] [Related]
30. Expression of TWEAK and its receptor Fn14 in human subcutaneous adipose tissue. Relationship with other inflammatory cytokines in obesity.
Chacón MR; Richart C; Gómez JM; Megía A; Vilarrasa N; Fernández-Real JM; García-España A; Miranda M; Masdevall C; Ricard W; Caubet E; Soler J; Vendrell J
Cytokine; 2006 Feb; 33(3):129-37. PubMed ID: 16503147
[TBL] [Abstract][Full Text] [Related]
31. Interleukin-13 damages intestinal mucosa via TWEAK and Fn14 in mice-a pathway associated with ulcerative colitis.
Kawashima R; Kawamura YI; Oshio T; Son A; Yamazaki M; Hagiwara T; Okada T; Inagaki-Ohara K; Wu P; Szak S; Kawamura YJ; Konishi F; Miyake O; Yano H; Saito Y; Burkly LC; Dohi T
Gastroenterology; 2011 Dec; 141(6):2119-2129.e8. PubMed ID: 21893119
[TBL] [Abstract][Full Text] [Related]
32. Novel function of TWEAK in inducing intervertebral disc degeneration.
Wako M; Haro H; Ando T; Hatsushika K; Ohba T; Iwabuchi S; Nakao A; Hamada Y
J Orthop Res; 2007 Nov; 25(11):1438-46. PubMed ID: 17568422
[TBL] [Abstract][Full Text] [Related]
33. Expression and function of fibroblast growth factor-inducible 14 in human corneal myofibroblasts.
Ebihara N; Nakayama M; Tokura T; Ushio H; Murakami A
Exp Eye Res; 2009 Aug; 89(2):256-62. PubMed ID: 19344712
[TBL] [Abstract][Full Text] [Related]
34. Considering TWEAK as a target for therapy in renal and vascular injury.
Ortiz A; Sanz AB; Muñoz García B; Moreno JA; Sánchez Niño MD; Martín-Ventura JL; Egido J; Blanco-Colio LM
Cytokine Growth Factor Rev; 2009 Jun; 20(3):251-8. PubMed ID: 19482507
[TBL] [Abstract][Full Text] [Related]
35. TWEAK promotes the production of Interleukin-17 in rheumatoid arthritis.
Park JS; Park MK; Lee SY; Oh HJ; Lim MA; Cho WT; Kim EK; Ju JH; Park YW; Park SH; Cho ML; Kim HY
Cytokine; 2012 Oct; 60(1):143-9. PubMed ID: 22819243
[TBL] [Abstract][Full Text] [Related]
36. Molecular characterization of the porcine GBP1 and GBP2 genes.
Ma G; Huang J; Sun N; Liu X; Zhu M; Wu Z; Zhao S
Mol Immunol; 2008 May; 45(10):2797-807. PubMed ID: 18346789
[TBL] [Abstract][Full Text] [Related]
37. Targeting fibroblast growth factor-inducible-14 signaling protects from chronic relapsing experimental autoimmune encephalomyelitis.
Mueller AM; Pedré X; Kleiter I; Hornberg M; Steinbrecher A; Giegerich G
J Neuroimmunol; 2005 Feb; 159(1-2):55-65. PubMed ID: 15652403
[TBL] [Abstract][Full Text] [Related]
38. Tumor necrosis factor-like weak inducer of apoptosis (TWEAK) enhances vascular and renal damage induced by hyperlipidemic diet in ApoE-knockout mice.
Muñoz-García B; Moreno JA; López-Franco O; Sanz AB; Martín-Ventura JL; Blanco J; Jakubowski A; Burkly LC; Ortiz A; Egido J; Blanco-Colio LM
Arterioscler Thromb Vasc Biol; 2009 Dec; 29(12):2061-8. PubMed ID: 19778942
[TBL] [Abstract][Full Text] [Related]
39. Adipocytes as immune cells: differential expression of TWEAK, BAFF, and APRIL and their receptors (Fn14, BAFF-R, TACI, and BCMA) at different stages of normal and pathological adipose tissue development.
Alexaki VI; Notas G; Pelekanou V; Kampa M; Valkanou M; Theodoropoulos P; Stathopoulos EN; Tsapis A; Castanas E
J Immunol; 2009 Nov; 183(9):5948-56. PubMed ID: 19828625
[TBL] [Abstract][Full Text] [Related]
40. TWEAK mediates anti-tumor effect of tumor-infiltrating macrophage.
Kaduka Y; Takeda K; Nakayama M; Kinoshita K; Yagita H; Okumura K
Biochem Biophys Res Commun; 2005 Jun; 331(2):384-90. PubMed ID: 15850771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
